Skip to main content

Champions Oncology, Inc. (CSBR)

NASDAQ: CSBR · IEX Real-Time Price · USD
10.00 0.00 (0.00%)
Oct 22, 2021 4:00 PM EDT - Market closed
Market Cap134.74M
Revenue (ttm)42.75M
Net Income (ttm)115,000
Shares Out13.40M
EPS (ttm)0.00
PE Ratio10,000.00
Forward PE101.01
Dividendn/a
Ex-Dividend Daten/a
Volume13,670
Open10.06
Previous Close10.00
Day's Range9.94 - 10.04
52-Week Range8.30 - 14.68
Beta1.13
AnalystsStrong Buy
Price Target15.67 (+56.7%)
Est. Earnings DateDec 13, 2021

About CSBR

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platfo...

IndustryLife Sciences Tools & Services
IPO DateMar 25, 1986
Employees194
Stock ExchangeNASDAQ
Ticker SymbolCSBR
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 3 analysts, the average rating for CSBR stock is "Strong Buy." The 12-month stock price forecast is 15.67, which is an increase of 56.70% from the latest price.

Price Target
$15.67
(56.70% upside)
Analyst Consensus: Strong Buy

News

Champions Oncology Expands Global Biomarker Capabilities with Opening of European Laboratory at OpenZone Life Science...

HACKENSACK, NJ / ACCESSWIRE / October 20, 2021 / Champions Oncology (NASDAQ:CSBR), a technology-enabled research organization announced the opening of a European laboratory located in the renowned OpenZ...

2 days ago - Accesswire

Champions Oncology, Inc. (CSBR) Reports Q1 Loss, Tops Revenue Estimates

Champions Oncology, Inc. (CSBR) delivered earnings and revenue surprises of -200.00% and 2.30%, respectively, for the quarter ended July 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Champions Oncology Reports Record Quarterly Revenue of $11.3 Million

HACKENSACK, NJ / ACCESSWIRE / September 13, 2021 / Champions Oncology, Inc. (Nasdaq:CSBR), leaders in transformative technology solutions utilized in drug discovery and development, today announced its ...

1 month ago - Accesswire

Champions Oncology, Inc. (CSBR) Reports Next Week: What You Should Expect

Champions Oncology, Inc. (CSBR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

Champions Oncology to Announce First Quarter Financial Results on Monday, September 13, 2021

HACKENSACK, NJ / ACCESSWIRE / September 2, 2021 / Champions Oncology, Inc. (CSBR), leaders in transformative technology solutionsutilized in oncology drug discovery and development will report its finan...

1 month ago - Accesswire

Champions Oncology Announces an Expanded Corporate Strategy to Include Drug Discovery and Development

HACKENSACK, NJ / ACCESSWIRE / July 26, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology solutions provider that is transforming drug discovery through innovative pharm...

2 months ago - Accesswire

Champions Oncology Reports Quarterly Revenue of $10.6 Million

Record Annual Revenue of $41 Million HACKENSACK, NJ / ACCESSWIRE / July 22, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), engaged in creating transformative technology solutions to be utilized in drug ...

3 months ago - Accesswire

Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 22, 2021

HACKENSACK, NJ / ACCESSWIRE / July 14, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology solutions provider engaged in transforming drug discovery through innovative ph...

3 months ago - Accesswire

Champions Oncology and BGI Americas Announce a Strategic Partnership to Provide Mass Spectrometry Proteomics, Metabol...

HACKENSACK, NJ / ACCESSWIRE / June 15, 2021 / Champions Oncology (NASDAQ:CSBR), a technology-enabled research organization announced today that they have entered into a strategic partnership with BGI Am...

4 months ago - Accesswire

Champions Oncology, Inc. (CSBR) Upgraded to Buy: What Does It Mean for the Stock?

Champions Oncology, Inc. (CSBR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

6 months ago - Zacks Investment Research

7 Micro-Cap Stocks to Buy That Are Shining Right Now

The markets keep going up as new stimulus spending and the massive new infrastructure bill hit. These micro-cap stocks are bargains.

6 months ago - InvestorPlace

Strength Seen in Champions Oncology, Inc. (CSBR): Can Its 15.3% Jump Turn into More Strength?

Champions Oncology, Inc. (CSBR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the...

7 months ago - Zacks Investment Research

Champions Oncology Reports Record Quarterly Revenue of $10.8 Million

HACKENSACK, NJ / ACCESSWIRE / March 11, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology solutions provider engaged in transforming drug discovery and development thro...

7 months ago - Accesswire

Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 11, 2021

HACKENSACK, NJ / ACCESSWIRE / March 5, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology solutions provider engaged in transforming drug discovery through innovative ph...

7 months ago - Accesswire

Analysts Estimate Champions Oncology, Inc. (CSBR) to Report a Decline in Earnings: What to Look Out for

Champions Oncology, Inc. (CSBR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

7 months ago - Zacks Investment Research

Champions Oncology Announces Partnership with Code Ocean to Expand the Functionality of Lumin Bioinformatics

HACKENSACK, NJ / ACCESSWIRE / January 19, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology company that is transforming drug discovery and development through data-dri...

9 months ago - Accesswire

Champions Oncology Announces the Expansion of Lumin Bioinformatics: Now Featuring a Highly Valuable Set of Proteomic ...

HACKENSACK, NJ / ACCESSWIRE / January 5, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology company that is transforming drug discovery and development through data-driv...

9 months ago - Accesswire

Champions Oncology (CSBR) Catches Eye: Stock Jumps 9.2%

Champions Oncology (CSBR) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.

1 year ago - Zacks Investment Research

Champions Oncology, Inc. (CSBR) CEO Ronnie Morris on Q1 2021 Results - Earnings Call Transcript

Champions Oncology, Inc. (CSBR) CEO Ronnie Morris on Q1 2021 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Recap: Champions Oncology Q1 Earnings

Shares of Champions Oncology (NASDAQ:CSBR) were unchanged in after-market trading after the company reported Q1 results.

1 year ago - Benzinga

Champions Oncology, Inc. (CSBR) CEO Ronnie Morris on Q4 2020 Results - Earnings Call Transcript

Champions Oncology, Inc. (CSBR) CEO Ronnie Morris on Q4 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Recap: Champions Oncology Q4 Earnings

Shares of Champions Oncology (NASDAQ:CSBR) rose 1.08% in after-market trading after the company reported Q4 results.

1 year ago - Benzinga

Champions Oncology, Inc. (CSBR) CEO Ronnie Morris on Q2 2020 Results - Earnings Call Transcript

Champions Oncology, Inc. (CSBR) CEO Ronnie Morris on Q2 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Champions Oncology, Inc. (CSBR) CEO Ronnie Morris on Q1 2020 Results - Earnings Call Transcript

Champions Oncology, Inc. (CSBR) CEO Ronnie Morris on Q1 2020 Results - Earnings Call Transcript

2 years ago - Seeking Alpha

Champions Oncology, Inc. (CSBR) CEO Ronnie Morris on Fiscal Q1 2020 Results - Earnings Call Transcript

Champions Oncology, Inc. (CSBR) CEO Ronnie Morris on Fiscal Q1 2020 Results - Earnings Call Transcript

2 years ago - Seeking Alpha